We improve the safety of patients, clinics, their staff and the environment by transforming the way infection prevention practices are understood and conducted, and introducing innovative technologies that deliver improved standards of care.
We are an innovator in infection prevention. Our unique, automated trophon® EPR high level disinfection device has paved the way around the world in setting a new standard of care in ultrasound probe disinfection practices.
trophon is a global solution for reducing cross contamination between patients and reducing the spread of Healthcare Acquired Infections (HAIs).
With a growing trend around the world towards stricter ultrasound probe reprocessing guidelines, traditional systems have been falling behind in their ability to meet today’s demanding requirements. The cutting edge technology used in trophon has really disrupted the disinfection market and was the first major innovation in ultrasound probe HLD in more than 20 years.
Nanosonics has broken new ground in completely re-thinking ultrasound reprocessing. trophon EPR was a breakthrough solution across three core areas: Safety, Versatility, and Simplicity.
Now, with the release of trophon2, Nanosonics has gone even further in providing the most advanced ultrasound high level disinfection solution in the world, offering:
Smart Protection: For patients, staff and the environment to reduce risk
Smart Flexibility: Streamlines set-up, can be customised to your workflow and has extensive probe compatibility to improve efficiency
Smart Functionality: Enhances user experience so you can perform HLD simply, automatically, and with confidence to increase compliance
Smart Traceability: Simplifies the creation of accurate digital records, all stored on your trophon2 to increase audit-readiness
Smart Integration: Delivers an upgradable option to seamlessly connect trophon2s to your hospital information system to simplify data access
Our story at a glance
FOUNDED IN 2001 and head-quartered in Sydney, Australia, Nanosonics listed on the Australian Securities Exchange (NAN) in 2007.
IN 2009, we launched trophon, our unique, automated technology for the HLD of intracavity and surface ultrasound probes.
IN MARCH 2015, Nanosonics was included in the Australian Stock Exchange ASX300 Index (Australia’s top 300 companies by market capitalisation). The following year, the company joined the Australian Stock Exchange ASX200 Index (Australia’s top 200 companies by market capitalisation).
IN AUGUST 2018, Nanosonics launched trophon®2, the latest innovation in ultrasound probe high level disinfection. We also launched trophon® Companion Wipes, the perfect partner to streamline ultrasound probe reprocessing.
TODAY we have offices in North America, Canada, the United Kingdom and Europe, employing more than 200 people.
Our technology is now available in North America, Canada, the United Kingdom, Ireland, Germany, France, Belgium, Italy, Denmark, Russia, Singapore, Hong Kong, Japan, Mexico, Australia and New Zealand.
Along the way we have formed channel partnerships with leading global brands for the distribution of trophon, supported by our expert team who understand infection prevention challenges.
We have a highly experienced team of professionals committed to providing HLD solutions for ultrasound probe use and have developed a deep understanding of our customers’ needs in infection prevention. Alongside our passion for product innovation, we are dedicated to research and are continually evolving trophon’s superior efficacy over other current disinfection methods.